SSG Advises Infinity Pharmaceuticals, Inc. in the Sale of Substantially all of its Assets to a Healthcare Investment Firm
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Infinity Pharmaceuticals, Inc. (the “Company”) in the sale of substantially all its assets to a healthcare investment firm. The sale was effectuated through a Chapter 11 Section 363….
READ MORESSG Capital Advisor’s 2023 Year in Review
We are proud of SSG Capital Advisors’ investment banking professionals and the Firm’s performance during 2023. For over two decades, we have been honored to work alongside many talented firms and professionals in forging a path ahead for middle….
READ MORESSG Advises Sanotech 360 in the Sale of Substantially all of its Assets to an Affiliate of Bio Surface Management Company, LLC
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Sanotech 360, LLC dba EMist (“EMist” or the “Company”), in the sale of substantially all of its assets to an affiliate of Bio Surface Management Company, LLC. The….
READ MORESSG Places Debt Financing for Winona Foods, Inc.
SSG Capital Advisors, LLC (“SSG”) acted as investment banker to Winona Foods, Inc. (“Winona Foods” or the “Company”) in the private placement of a term loan. The term loan was placed alongside a revolving credit facility. The new financing was utilized….
READ MORESSG Advises EFS Parlin Holdings, LLC in the Sale of its Interconnection Rights to TigerGenCo, LLC
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to EFS Parlin Holdings, LLC (“Parlin” or the “Company”) in the sale of its Interconnection Rights to TigerGenCo, LLC (“TigerGenCo”). The sale was effectuated through a Chapter 11 Section….
READ MORE